Sintilimab Combined With Docetaxel Monotherapy

DRUG2 trials

Sponsors

Yongchang Zhang, Ye jinjun

Conditions

Esophageal Squamous Cell Carcinoma (ESCC)Non-small Cell Lung Cancer

Phase 2

Sintilimab Combined With Docetaxel for Standard Chemotherapy Failure Non-driver Gene Mutation Metastatic Non-small Cell Lung Cancer

CompletedNCT04144582

Yongchang ZhangNon-small Cell Lung Cancer

Start: 2019-01-01End: 2021-12-31Updated: 2022-03-02

Phase 3

Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy

Enrolling by invitationNCT07016737

Ye jinjunEsophageal Squamous Cell Carcinoma (ESCC)

Start: 2024-08-01End: 2029-09-01Target: 79Updated: 2025-06-12